UKIPO report of IP trends for UK Higher Education Institutions highlights life sciences innovation

No items found.
​
April 30, 2020

On 29 April 2020, the UKIPO published an overview report of IP trends for UK Higher Education Institutions (HEIs) and their spin-out businesses, between 1999 and 2018. We focus on some of the main takeaways and trends from this overview for the life sciences sector below.

The report highlights the value that UK universities place on life sciences innovation, as reflected by the impressive percentage of patent publications in the fields of Biotechnology and Pharmaceuticals. Indeed, 47 % of UK HEI patent publications are in the Chemistry sector (over 50% of which used pharmaceuticals and biotechnology IPC technology fields), compared to 21% of all patent publications globally.

Notably, there was a rise in the level of international collaboration between UK HEIs and entities abroad, particularly in the US. This trend demonstrates both the aim of universities to more effectively exploit their IP commercially and the importance of collaboration for the transfer of technology.

Life sciences powerhouses Imperial College London, UCL and Oxford University were among those institutions showing not only the largest output of published applications, but also the greatest proportional increase in activity. Furthermore, of the top 10 spin-out businesses, according to the number of applications, six of these have a biotechnological focus, including DNA sequencing products, biotherapeutics and drug discovery.

The importance of innovation within the life sciences sector to UK universities, and the UK as a whole, is clear from this report. As we move into the era of personalised medicine and with Artificial Intelligence and machine learning becoming increasingly significant in healthcare innovation, it will be interesting to see whether UK HEIs continue to lead in this new era and whether more and more computer technology related patent filings over the next 20 years will be important to the healthcare sector.

Recent Case Reports

Qualified electronic signatures not necessary at the UPC after all
17 November 2026
The UPC Court of Appeal confirmed that a scanned handwritten signature satisfies R. 4.1 RoP, and that a qualified or advanced electronic signature is not required. It also upheld the Brussels Local Division's decision to keep Dutch as the language of proceedings, as all parties are Flemish-based and the claimant is a small enterprise.
Milan Local Division: formal and sequential evaluation of infringement notice under FRAND
17 November 2026
The Milan Local Division held that an SEP holder with a dominant position must, before commencing an action seeking an injunction, identify the asserted patent and explain how it is allegedly infringed sufficiently early to permit a genuine response. Notice given on the filing date, could not cure the omission, and this was not altered by the fact the injunction request was conditional.
Invalidity of juicer patent upheld on appeal
03 November 2026
The Court of Appeal upheld the invalidity of Hurom’s juicer patent for lack of inventive step, while clarifying the admissibility requirements for patent amendments and the use of the unamended description when construing amended claims. It also confirmed the UPC’s jurisdiction over infringement in Poland despite Poland not being a UPCA Contracting Member State, but found that Hurom had failed to establish infringement under Polish law.